---
schema_version: "secwatch.filing_event.v1"
accession: "0001564590-22-021755"
form_type: "8-K"
ticker: "TXMD"
cik: "0000025743"
company_name: "TherapeuticsMD, Inc."
filed_at: "2022-05-31T23:59:59+00:00"
generated_at: "2026-06-25T06:01:48.388152+00:00"
event_type: "m_and_a"
sentiment: "positive"
materiality_score: 1.0
calibrated_materiality_score: 1.0
confidence: "high"
source: SEC EDGAR
---

# TherapeuticsMD to be acquired by EW Healthcare Partners for $10.00/share in all-cash deal

## Summary
- Offer price of $10.00 per share represents 367.3% premium over May 27 closing price.
- Total enterprise value approx. $177 million; tender offer to commence by June 6, 2022.
- Board unanimously approved; no stockholder vote required under Nevada law.
- Financing: $93M equity commitment from EW; Sixth Street debt amended with interest pause and maturity extended to July 13, 2022.
- If merger fails to close by July 13, 2022, events of default under financing agreement could impact going concern.

## SEC filing metadata
- accession: 0001564590-22-021755
- form_type: 8-K
- ticker: TXMD
- cik: 0000025743
- company_name: TherapeuticsMD, Inc.
- filed_at: 2022-05-31T23:59:59+00:00
- event_type: m_and_a
- sentiment: positive
- materiality_score: 1.0
- calibrated_materiality_score: 1.0
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/25743/000156459022021755/0001564590-22-021755-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/25743/000156459022021755/txmd-8k_20220527.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001564590-22-021755
- JSON: https://secwatch.observer/filing/0001564590-22-021755.json
- Plain text: https://secwatch.observer/filing/0001564590-22-021755.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.